COMP <GO>
MRVL vs CRM // EV/EBITDA & P/E VALUATION
Marvell Technology Inc. (NASDAQ) VS. Salesforce, Inc. (NYSE) • 15-METRIC TALLY: MRVL 5
— CRM 9
▲ EV/EBITDA & P/E VALUATION LEADER: CRM
LAST: $196.40 (-10.05%) • MKT CAP: $191.46B
valuation
95.0x
LAST: $229.17 (-0.75%) • MKT CAP: $190.03B
valuation
18.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MRVL VS. CRM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MRVL | CRM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.00% | 77.28% | -26.28 | CRM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.70% | 9.95% | -3.25 | CRM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 95.0x | 18.7x | +76.27 | CRM | /valuation <GO> |
| Free Cash Flow Yield | 0.73% | 8.03% | -7.30 | CRM | /fcf-yield <GO> |
| Operating Margin | 16.10% | 19.88% | -3.78 | CRM | /operating-margins <GO> |
| Net Profit Margin | 32.60% | 21.99% | +10.61 | MRVL | /net-margins <GO> |
| Revenue Growth (YoY) | 42.10% | 11.23% | +30.87 | MRVL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.11% | 0.77% | -0.66 | CRM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 15.22 | 2.55 | +12.67 | MRVL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | MRVL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 10.87% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.9 | 55.5 | -12.60 | CRM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 1.37 | -0.22 | CRM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 60.2x | 14.2x | +46.05 | CRM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $191.46B | $190.03B | $1.43B | MRVL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MRVL REV | CRM REV | MRVL GROSS % | CRM GROSS % | MRVL FCF | CRM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.19B | $41.52B | 51.0% | 77.7% | $1.40B | $14.40B |
| FY 2024 | $5.77B | $37.90B | 41.3% | 77.2% | $1.40B | $12.43B |
| FY 2023 | $5.51B | $34.86B | — | 75.5% | $1.12B | $9.50B |
| FY 2022 | — | $31.35B | — | 73.3% | — | $6.31B |
| FY 2021 | — | $26.49B | — | 73.5% | — | $5.28B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MRVL // BETA 1.15
CRM // BETA 1.37